Aetiology and therapy of community-acquired pneumonia: A hospital study in northern Italy

European Journal of Clinical Pharmacology

Volumn 51, Issue 6, 1997, Pages 437-443

  Guglielmo, L ^a   Leone, R ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Community acquired; Inpatients; Microbiology; Pneumonia; Therapeutic protocol

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ADENOVIRUS; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BLOOD ANALYSIS; CHLAMYDIACEAE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXIELLA BURNETII; DRUG COST; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; HEALTH CARE QUALITY; HOSPITAL DEPARTMENT; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ITALY; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOPLASMA PNEUMONIAE; ORAL DRUG ADMINISTRATION; PARAINFLUENZA VIRUS; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RADIODIAGNOSIS; RISK ASSESSMENT; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VIRUS CHARACTERIZATION;

ANTI-INFECTIVE AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMPUTER-ASSISTED; FEMALE; HOSPITALS; HUMANS; ITALY; MALE; MIDDLE AGED; PNEUMONIA; RISK FACTORS;

EID: 0030853461     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050227     Document Type: Article

References (40)

1. Garibaldi RA (1985) Epidemiology of community-acquired respiratory tract infections in adults. Am J Med 78 [Suppl 6B]: 32-37
2. Macfarlane J (1994) An overview of community acquired pneumonia with lessons learned from the British Thoracic Society study. Semin Respir Infect 9: 153-165
3. Woodhead MA, Arrow-smith J, Chamberlain-Webber R, Wooding S, Williams I (1991) The value of routine microbial investigation in community-acquired pneumonia. Respir Med 85: 313-317
4. Niederman MS (1994) Empirical therapy of community-acquired pneumonia. Semin Respir Infect 9: 192-198
5. French N, Parry C, Wong R, Hind CRK (1993) The value of microbiological investigation of community acquired pneumonia in relation to disease severity. Thorax 48 [Abstract]: 1052-1053
6. Grasela TH Jr, Welage LS, Walawander CA, Timm EG, Peltee MA, Poirier TI, Waltees JK (1990) A nationwide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumonia. Drus InTell Clin Pharm 24: 1220-1225
7. Guglielmo L, Leone R, Moretti U, Conforti A, Spolaor A, Velo G (1993) Antibiotic prescribing patterns in Italian hospital inpatients with pneumonia, chronic obstructive pulmonary disease, and urinary tract infections. Ann Pharmacother 27: 18-22
8. Janknegt R, Wijnands WJA, Stobberingh EE (1994) Antibiotic policies in Dutch hospitals for the treatment of pneumonia. J Antimicrob Chemother 34: 431-442
9. Kappstein I, Daschner FD (1991) Antibiotic usage in community-acquired pneumonia: results of a survey in 288 departments of internal medicine in German hospitals. Infection 19: 301-304
10. Cooke D, Salter AJ, Phillips I (1980) Antimicrobial misuse, antibiotic policies and information resources. J Antimicrob Chemother 6: 435-443
11. Chow JW, Yu VL (1989) Antibiotic studies in pneumonia. Chest 96: 453-455
12. Fass RJ (1993) Aetiology and treatment of community-acquired pneumonia in adults: an historical prospective. J Antimicrob Chemother 32 [Suppl A]: 17-27
13. Kapoor WN (1994) Design of outcome studies of community-acquired pneumonia. Semin Respir Infect 9: 214-219
14. British Thoracic Society, London (1993) Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 9: 346-350
15. American Thoracic Society (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148: 1418-1426
16. Mandell LA, Niederman MS (1993) The Canadian Community Acquired Pneumonia Consesus Group. Antimicrobial treatment of community acquired pneumonia in adults: a conference report. Can J Infect Dis 4: 25-28
17. Gialdroni Grassi G, Bianchi L (1995) Guidelines for the management of community-acquired pneumonia in adults. Monaldi Arch Chest Dis 50: 21-27
18. Davey PG, Malek MoM, Sharon EP (1992) Pharmacoeconomics of antibacterial treatment. Pharmacoeconomics 1: 409-437
19. Guglielmo BJ, Brooks GF (1989) Antimicrobial therapy. Drugs 38: 473-480
20. British Thoracic Society (1987) Community-acquired pneumonia in British hospitals in 1982-83: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med 62: 195-220
21. Bartlett JG, Mundy LM (1995) Community-acquired pmeumonia. N Engl J Med 333: 1618-1624
22. Donowitz GR, Mandell GL (1990) Acute pneumonia. In: Mandell GL, Douglas R, Bennet JE (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York, pp 540-555
23. Cunha BA (1991) Atypical pneumonias. Postgrad Med 90: 89-101
24. Schito GC, Grazi G, Dainelli B, Catamo G, Satta G, Grillo RL, Stefani S, Russo G (1994) Incidence of lower respiratory tract infections caused by Mycoplasma, Chlamydia and Legionella: an Italian multicenter survey. J Chemother 6: 319-321
25. Appelbaum PC (1992) Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 15: 77-83
26. Davis R, Bryson HM (1994) Ceftriaxone. Pharmacoeconomics 6: 249-269
27. Pocock SJ (1983) Clinical trials: a practical approach. John Wiley and Sons, Chichester
28. Mittl RL, Schwab RJ, Duchin JS, Goin JE, Albeida SM, Miller WT (1994) Radiographic resolution of community-acquired pneumonia. Am J Respir Crit Care Med 149: 630-635
29. Sanders WE, Morris JF, Alessi P, Makeis AT, McCloskey RV, Teenholme GM, Lannini P, Bittner MJ (1991) Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a non-traditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trial. Am J Med 91: 261-266
30. Örtqvist Å (1994) Initial investigation and treatment of the patient with severe community-acquired pneumonia. Semin Respir Infect 9: 166-179
31. Jubber AS, Woodhead MA (1993) Functional status and microbiology in community acquired pneumonia (CAP) in the elderly. Thorax 48 [Abstract]: 1067
32. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG (1987) Prospective study of the aetiology and outcome of pneumonia in the community. Lancet i: 671-674
33. Slack R, McCabe M, Bucknall CE, Stevenson RDS, Winter J (1993) Audit of hospital management of pneumonia (I). Thorax 48 [Abstract]: 462-463
34. Weingarten SR, Riedinger MS, Varis G, Noah MS, Belman MJ, Meyer RD, Ellrodt AG (1994) Identification of low-risk hospitalized patients with pneumonia. Chest 105: 1109-1115
35. Fine MJ, Smith DN, Singer DE (1990) Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med 89: 713-721
36. Karalus NC, Cursons RT, Leng RA, Mahood CB, Rothwell RP, Hancock B, Cepulis S, WawaTai M, Coleman L (1991) Community acquired pneumonia: aetiology and prognostic index evaluation. Thorax 46: 413-418
37. Woodhead MA (1992) Management of pneumonia. Respir Med 86: 459-469
38. May HM, Harrison TS, Harrison DW (1994) A criterion based audit of community-acquired pneumonia. Respir Med 88: 693-696
39. MacDonald KS, Scriver SR, Skulnick M, Low DE (1994) Community-acquired pneumonia: the future of the microbiology laboratory: focused diagnosis or syndromic management? Semin Respir Infect 9: 180-188
40. Davies BI (1994) Critical review of microbiological data and methods in diagnosis of lower respiratory tract infections. Monaldi Arch Chest Dis 49: 52-56